Upregulation of PDK4 is observed in high-grade invasive bladder cancers compared with low-grade bladder cancers, and Knockdown or inactivation of PDK4 delays cell proliferation and sensitizes bladder cancer cells to cisplatin (Woolbright et al., 2018). This evidence concerns the gene PDK4 and urinary bladder cancer.